Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK), maintaining a price target of $135. This reaffirms the firm's positive outlook on the stock.
March 11, 2024 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirmed an Overweight rating on Merck & Co, with a maintained price target of $135, indicating a positive outlook on the stock.
The reiteration of an Overweight rating and the maintenance of a $135 price target by a reputable analyst like Louise Chen from Cantor Fitzgerald could signal strong confidence in Merck & Co's future performance. This endorsement is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100